December 31, 2019
2 min read
Save

Low incidence of unplanned admission found after hip arthroscopy

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Patients had a low incidence of 30-day unplanned admission after hip arthroscopy, with chronic corticosteroid use, perioperative transfusions and greater BMI identified as independent risk factors, according to published results.

Michael J. Salata , MD, and colleagues used CPT, ICD-9 and ICD-10 codes to identify 1,931 patients who underwent hip arthroscopy in the American College of Surgeons National Surgical Quality Improvement Program database. Researchers compared demographics, comorbidities, preoperative laboratory values, surgical details and postoperative outcomes of patients with planned and unplanned admissions after hip arthroscopy.

Within 30 days of the index procedure, results showed an unplanned admission rate of 0.9%, with a median time to unplanned admission of 14.5 days. Researchers found surgical site infection, wound complications and thromboembolic events as the most common reasons for admission. According to results, 22.2% of patients required reoperation and 39% of patients were readmitted for reasons unrelated to the index hip arthroscopy procedure. Multivariate analysis showed an increased risk for unplanned admission was independently associated with chronic corticosteroid use, perioperative blood transfusion and increasing BMI.

“Evaluation of patients’ incisions within the first week to 10 days and some form of thromboembolic prophylaxis would seem to be ways to attempt to prevent these most common reasons for readmission,” Salata told Healio Orthopedics. – by Casey Tingle

Disclosures: Salata reports he received personal fees from Stryker Corporation. Please see the study for all other authors’ relevant financial disclosures.